HealthEquity Inc (HQY) - Net Assets

Latest as of January 2026: $2.11 Billion USD

Based on the latest financial reports, HealthEquity Inc (HQY) has net assets worth $2.11 Billion USD as of January 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($3.43 Billion) and total liabilities ($1.32 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check HQY financial resilience to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric Value
Current Net Assets $2.11 Billion
% of Total Assets 61.4%
Annual Growth Rate 36.19%
5-Year Change 13.74%
10-Year Change 704.46%
Growth Volatility 84.66

HealthEquity Inc - Net Assets Trend (2013–2026)

This chart illustrates how HealthEquity Inc's net assets have evolved over time, based on quarterly financial data. Also explore HQY asset base for the complete picture of this company's asset base.

Annual Net Assets for HealthEquity Inc (2013–2026)

The table below shows the annual net assets of HealthEquity Inc from 2013 to 2026. For live valuation and market cap data, see HQY company net worth.

Year Net Assets Change
2026-01-31 $2.11 Billion -0.36%
2025-01-31 $2.11 Billion +3.93%
2024-01-31 $2.04 Billion +7.35%
2023-01-31 $1.90 Billion +2.32%
2022-01-31 $1.85 Billion +34.37%
2021-01-31 $1.38 Billion +33.82%
2020-01-31 $1.03 Billion +115.96%
2019-01-31 $477.08 Million +37.77%
2018-01-31 $346.27 Million +32.20%
2017-01-31 $261.94 Million +28.74%
2016-01-31 $203.46 Million +41.20%
2015-01-31 $144.09 Million +323.71%
2014-01-31 $34.01 Million -10.50%
2013-01-31 $38.00 Million --

Equity Component Analysis

This analysis shows how different components contribute to HealthEquity Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 21497500000.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (January 2026)

Component Amount Percentage
Retained Earnings $195.91 Million 9.30%
Common Stock $8.00K 0.00%
Other Comprehensive Income $-5.71 Million -0.27%
Other Components $1.92 Billion 90.97%
Total Equity $2.11 Billion 100.00%

HealthEquity Inc Competitors by Market Cap

The table below lists competitors of HealthEquity Inc ranked by their market capitalization.

Company Market Cap
RATIONAL UN.ADR 1/ 1/20
F:RAA1
 $6.96 Billion
Cidara Therapeutics Inc
NASDAQ:CDTX
 $6.96 Billion
New Gold Inc
TO:NGD
 $6.96 Billion
Abivax SA
PA:ABVX
 $6.97 Billion
Nippon Life India Asset Management Limited
NSE:NAM-INDIA
 $6.96 Billion
Ingredion Incorporated
NYSE:INGR
 $6.96 Billion
BILIBILI INC. DL -0001
F:71BB
 $6.96 Billion
Pegatron Corp
TW:4938
 $6.95 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in HealthEquity Inc's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2025 to 2026, total equity changed from 2,114,911,000 to 2,107,196,000, a change of -7,715,000 (-0.4%).
  • Net income of 215,201,000 contributed positively to equity growth.
  • Share repurchases of 299,254,000 reduced equity.
  • Other comprehensive income decreased equity by 5,707,000.
  • Other factors increased equity by 82,045,000.

Equity Change Factors (2025 to 2026)

Factor Impact Contribution
Net Income $215.20 Million +10.21%
Share Repurchases $299.25 Million -14.2%
Other Comprehensive Income $-5.71 Million -0.27%
Other Changes $82.05 Million +3.89%
Total Change $- -0.36%

Book Value vs Market Value Analysis

This analysis compares HealthEquity Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 3.42x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has decreased from 106.10x to 3.42x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2013-01-31 $0.78 $82.40 x
2014-01-31 $0.75 $82.40 x
2015-01-31 $2.78 $82.40 x
2016-01-31 $3.46 $82.40 x
2017-01-31 $4.37 $82.40 x
2018-01-31 $5.60 $82.40 x
2019-01-31 $7.53 $82.40 x
2020-01-31 $15.05 $82.40 x
2021-01-31 $18.22 $82.40 x
2022-01-31 $22.28 $82.40 x
2023-01-31 $22.45 $82.40 x
2024-01-31 $23.40 $82.40 x
2025-01-31 $23.81 $82.40 x
2026-01-31 $24.09 $82.40 x

Capital Efficiency Dashboard

This dashboard shows how efficiently HealthEquity Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 10.21%
  • The company shows good efficiency in utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 16.38%
  • • Asset Turnover: 0.38x
  • • Equity Multiplier: 1.63x
  • Recent ROE (10.21%) is above the historical average (7.69%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2013 31.37% 24.23% 1.00x 1.30x $7.61 Million
2014 3.63% 1.99% 1.13x 1.62x $-2.17 Million
2015 7.06% 11.57% 0.55x 1.10x $-4.24 Million
2016 8.17% 13.10% 0.58x 1.08x $-3.73 Million
2017 10.07% 14.79% 0.64x 1.07x $182.00K
2018 13.68% 20.63% 0.62x 1.07x $12.73 Million
2019 15.49% 25.73% 0.56x 1.07x $26.19 Million
2020 3.85% 7.46% 0.21x 2.49x $-63.37 Million
2021 0.64% 1.20% 0.27x 1.97x $-129.04 Million
2022 -2.39% -5.85% 0.24x 1.68x $-229.55 Million
2023 -1.38% -3.03% 0.28x 1.63x $-215.71 Million
2024 2.74% 5.57% 0.32x 1.55x $-147.79 Million
2025 4.57% 8.06% 0.35x 1.63x $-114.79 Million
2026 10.21% 16.38% 0.38x 1.63x $4.48 Million

Industry Comparison

This section compares HealthEquity Inc's net assets metrics with peer companies in the Health Information Services industry.

Industry Context

  • Industry: Health Information Services
  • Average net assets among peers: $363,436,353
  • Average return on equity (ROE) among peers: -160.56%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
HealthEquity Inc (HQY) $2.11 Billion 31.37% 0.63x $6.96 Billion
Aclarion Inc (ACON) $2.23 Million -317.55% 0.31x $1.99 Million
American Well Corp (AMWL) $480.19 Million -140.60% 0.23x $90.87 Million
Heartbeam Inc (BEAT) $-26.87 Million 0.00% 0.00x $30.37 Million
Bullfrog AI Holdings, Inc. Common Stock (BFRG) $-3.06 Million 0.00% 0.00x $6.51 Million
BrightSpring Health Services, Inc. Common Stock (BTSG) $612.55 Million -25.24% 8.03x $8.82 Billion
Carlsmed, Inc. Common Stock (CARL) $-70.63 Million 0.00% 0.00x $253.42 Million
CareCloud Inc. (CCLD) $101.25 Million -8.70% 0.36x $117.28 Million
Certara Inc (CERT) $492.05 Million -1.81% 1.11x $983.48 Million
CareMax Inc (CMAX) $61.44 Million -1112.15% 9.14x $381.50
Claritev Corporation (CTEV) $1.99 Billion 0.49% 3.21x $277.75 Million

About HealthEquity Inc

NASDAQ:HQY USA Health Information Services
Market Cap
$6.96 Billion
Market Cap Rank
#2870 Global
#1001 in USA
Share Price
$82.40
Change (1 day)
+0.45%
52-Week Range
$73.21 - $113.06
All Time High
$114.51
Categories
Companies in USA Health Information Services Technology
About

HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. It offers health savings accounts (HAS); investment platform; online-only automated investment advisory services through Advisor, a Web-based tool. The company also provides flexible spending accounts (FSA) for health and dependent care; health reimbursement arrangements; and Consoli… Read more